{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:53:28Z","timestamp":1785236008071,"version":"3.55.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T00:00:00Z","timestamp":1755993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T00:00:00Z","timestamp":1755993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","award":["N42A670594,N42A6603, RGJ01,"],"award-info":[{"award-number":["N42A670594,N42A6603, RGJ01,"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","award":["N42A670594,N42A6603, RGJ01,"],"award-info":[{"award-number":["N42A670594,N42A6603, RGJ01,"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","award":["N42A670594,N42A6603, RGJ01,"],"award-info":[{"award-number":["N42A670594,N42A6603, RGJ01,"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","award":["N42A670594,N42A6603, RGJ01,"],"award-info":[{"award-number":["N42A670594,N42A6603, RGJ01,"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002842","name":"Chiang Mai University","doi-asserted-by":"publisher","award":["Center of Excellence Award"],"award-info":[{"award-number":["Center of Excellence Award"]}],"id":[{"id":"10.13039\/501100002842","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-17275-9","type":"journal-article","created":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T16:33:47Z","timestamp":1756053227000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pharmacological inhibition of apoptosis, necroptosis, and ferroptosis confers effective cardioprotection in post-myocardial infarction in rats"],"prefix":"10.1038","volume":"15","author":[{"given":"Chanon","family":"Piamsiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chayodom","family":"Maneechote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kewarin","family":"Jinawong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Busarin","family":"Arunsak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Titikorn","family":"Chunchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siriporn C.","family":"Chattipakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nipon","family":"Chattipakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,24]]},"reference":[{"key":"17275_CR1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/ehf2.13144","volume":"8","author":"D Jenca","year":"2021","unstructured":"Jenca, D. et al. Heart failure after myocardial infarction: incidence and predictors. ESC Heart Fail. 8, 222\u2013237. https:\/\/doi.org\/10.1002\/ehf2.13144 (2021).","journal-title":"ESC Heart Fail."},{"key":"17275_CR2","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","volume":"145","author":"CW Tsao","year":"2022","unstructured":"Tsao, C. W. et al. Heart disease and stroke Statistics-2022 update: A report from the American heart association. Circulation 145, e153\u2013e639. https:\/\/doi.org\/10.1161\/CIR.0000000000001052 (2022).","journal-title":"Circulation"},{"key":"17275_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12967-017-1191-y","volume":"15","author":"E Teringova","year":"2017","unstructured":"Teringova, E. & Tousek, P. Apoptosis in ischemic heart disease. J. Transl Med. 15, 87. https:\/\/doi.org\/10.1186\/s12967-017-1191-y (2017).","journal-title":"J. Transl Med."},{"key":"17275_CR4","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1161\/ATVBAHA.111.224907","volume":"31","author":"Y Zheng","year":"2011","unstructured":"Zheng, Y., Gardner, S. E. & Clarke, M. C. Cell death, damage-associated molecular patterns, and sterile inflammation in cardiovascular disease. Arterioscler. Thromb. Vasc Biol. 31, 2781\u20132786. https:\/\/doi.org\/10.1161\/ATVBAHA.111.224907 (2011).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"17275_CR5","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1152\/physrev.00022.2018","volume":"99","author":"DP Del Re","year":"2019","unstructured":"Del Re, D. P., Amgalan, D., Linkermann, A., Liu, Q. & Kitsis, R. N. Fundamental mechanisms of regulated cell death and implications for heart disease. Physiol. Rev. 99, 1765\u20131817. https:\/\/doi.org\/10.1152\/physrev.00022.2018 (2019).","journal-title":"Physiol. Rev."},{"key":"17275_CR6","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1111\/jcmm.17275","volume":"26","author":"Y Luo","year":"2022","unstructured":"Luo, Y. et al. Therapeutic potentials of cell death inhibitors in rats with cardiac ischaemia\/reperfusion injury. J. Cell. Mol. Med. 26, 2462\u20132476. https:\/\/doi.org\/10.1111\/jcmm.17275 (2022).","journal-title":"J. Cell. Mol. Med."},{"key":"17275_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12967-023-03873-6","volume":"21","author":"C Piamsiri","year":"2023","unstructured":"Piamsiri, C. et al. GSDMD-mediated pyroptosis dominantly promotes left ventricular remodeling and dysfunction in post-myocardial infarction: a comparison across modes of programmed cell death and mitochondrial involvement. J. Transl Med. 21, 16. https:\/\/doi.org\/10.1186\/s12967-023-03873-6 (2023).","journal-title":"J. Transl Med."},{"key":"17275_CR8","doi-asserted-by":"publisher","first-page":"113915","DOI":"10.1016\/j.bcp.2020.113915","volume":"175","author":"H Zhang","year":"2020","unstructured":"Zhang, H. et al. Necroptosis mediated by impaired autophagy flux contributes to adverse ventricular remodeling after myocardial infarction. Biochem. Pharmacol. 175, 113915. https:\/\/doi.org\/10.1016\/j.bcp.2020.113915 (2020).","journal-title":"Biochem. Pharmacol."},{"key":"17275_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12929-021-00722-w","volume":"28","author":"C Piamsiri","year":"2021","unstructured":"Piamsiri, C., Maneechote, C., Siri-Angkul, N., Chattipakorn, S. C. & Chattipakorn, N. Targeting necroptosis as therapeutic potential in chronic myocardial infarction. J. Biomed. Sci. 28, 25. https:\/\/doi.org\/10.1186\/s12929-021-00722-w (2021).","journal-title":"J. Biomed. Sci."},{"key":"17275_CR10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/eci.12391","volume":"45","author":"S Koudstaal","year":"2015","unstructured":"Koudstaal, S. et al. Necrostatin-1 alleviates reperfusion injury following acute myocardial infarction in pigs. Eur. J. Clin. Invest. 45, 150\u2013159. https:\/\/doi.org\/10.1111\/eci.12391 (2015).","journal-title":"Eur. J. Clin. Invest."},{"key":"17275_CR11","doi-asserted-by":"publisher","first-page":"105297","DOI":"10.1016\/j.phrs.2020.105297","volume":"163","author":"L Cao","year":"2021","unstructured":"Cao, L. & Mu, W. Necrostatin-1 and necroptosis inhibition: pathophysiology and therapeutic implications. Pharmacol. Res. 163, 105297. https:\/\/doi.org\/10.1016\/j.phrs.2020.105297 (2021).","journal-title":"Pharmacol. Res."},{"key":"17275_CR12","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/s12276-021-00634-7","volume":"53","author":"J Seo","year":"2021","unstructured":"Seo, J., Nam, Y. W., Kim, S., Oh, D. B. & Song, J. Necroptosis molecular mechanisms: recent findings regarding novel necroptosis regulators. Exp. Mol. Med. 53, 1007\u20131017. https:\/\/doi.org\/10.1038\/s12276-021-00634-7 (2021).","journal-title":"Exp. Mol. Med."},{"key":"17275_CR13","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nrm2970","volume":"11","author":"P Vandenabeele","year":"2010","unstructured":"Vandenabeele, P., Galluzzi, L., Vanden Berghe, T. & Kroemer, G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat. Rev. Mol. Cell. Biol. 11, 700\u2013714. https:\/\/doi.org\/10.1038\/nrm2970 (2010).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"17275_CR14","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1021\/ja411006a","volume":"136","author":"R Skouta","year":"2014","unstructured":"Skouta, R. et al. Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J. Am. Chem. Soc. 136, 4551\u20134556. https:\/\/doi.org\/10.1021\/ja411006a (2014).","journal-title":"J. Am. Chem. Soc."},{"key":"17275_CR15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/sj.cdd.4402044","volume":"14","author":"D Chauvier","year":"2007","unstructured":"Chauvier, D., Ankri, S., Charriaut-Marlangue, C., Casimir, R. & Jacotot, E. Broad-spectrum caspase inhibitors: from myth to reality? Cell. Death Differ. 14, 387\u2013391. https:\/\/doi.org\/10.1038\/sj.cdd.4402044 (2007).","journal-title":"Cell. Death Differ."},{"key":"17275_CR16","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41420-021-00698-4","volume":"7","author":"S Liao","year":"2021","unstructured":"Liao, S. et al. Cell death inhibitors protect against brain damage caused by cardiac ischemia\/reperfusion injury. Cell. Death Discov. 7, 312. https:\/\/doi.org\/10.1038\/s41420-021-00698-4 (2021).","journal-title":"Cell. Death Discov"},{"key":"17275_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/sj.bjp.0703336","volume":"130","author":"MM Mocanu","year":"2000","unstructured":"Mocanu, M. M., Baxter, G. F. & Yellon, D. M. Caspase Inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury. Br. J. Pharmacol. 130, 197\u2013200. https:\/\/doi.org\/10.1038\/sj.bjp.0703336 (2000).","journal-title":"Br. J. Pharmacol."},{"key":"17275_CR18","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1021\/acscentsci.7b00028","volume":"3","author":"O Zilka","year":"2017","unstructured":"Zilka, O. et al. On the mechanism of cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death. ACS Cent. Sci. 3, 232\u2013243. https:\/\/doi.org\/10.1021\/acscentsci.7b00028 (2017).","journal-title":"ACS Cent. Sci."},{"key":"17275_CR19","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s12640-020-00164-6","volume":"37","author":"D Jantas","year":"2020","unstructured":"Jantas, D., Chwastek, J., Grygier, B. & Lason, W. Neuroprotective effects of Necrostatin-1 against oxidative Stress-Induced cell damage: an involvement of cathepsin D Inhibition. Neurotox. Res. 37, 525\u2013542. https:\/\/doi.org\/10.1007\/s12640-020-00164-6 (2020).","journal-title":"Neurotox. Res."},{"key":"17275_CR20","doi-asserted-by":"publisher","first-page":"101328","DOI":"10.1016\/j.redox.2019.101328","volume":"28","author":"G Miotto","year":"2020","unstructured":"Miotto, G. et al. Insight into the mechanism of ferroptosis Inhibition by ferrostatin-1. Redox Biol. 28, 101328. https:\/\/doi.org\/10.1016\/j.redox.2019.101328 (2020).","journal-title":"Redox Biol."},{"key":"17275_CR21","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1002\/cphy.c150006","volume":"5","author":"NG Frangogiannis","year":"2015","unstructured":"Frangogiannis, N. G. Pathophysiology of myocardial infarction. Compr. Physiol. 5, 1841\u20131875. https:\/\/doi.org\/10.1002\/cphy.c150006 (2015).","journal-title":"Compr. Physiol."},{"key":"17275_CR22","doi-asserted-by":"publisher","first-page":"647785","DOI":"10.3389\/fcvm.2021.647785","volume":"8","author":"NJ Pluijmert","year":"2021","unstructured":"Pluijmert, N. J., Atsma, D. E. & Quax, P. H. A. Post-ischemic myocardial inflammatory response: A complex and dynamic process susceptible to Immunomodulatory therapies. Front. Cardiovasc. Med. 8, 647785. https:\/\/doi.org\/10.3389\/fcvm.2021.647785 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"17275_CR23","doi-asserted-by":"publisher","first-page":"750510","DOI":"10.3389\/fcvm.2021.750510","volume":"8","author":"AM Lodrini","year":"2021","unstructured":"Lodrini, A. M. & Goumans, M. J. Cardiomyocytes cellular phenotypes after myocardial infarction. Front. Cardiovasc. Med. 8, 750510. https:\/\/doi.org\/10.3389\/fcvm.2021.750510 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"17275_CR24","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1161\/01.cir.95.2.320","volume":"95","author":"A Saraste","year":"1997","unstructured":"Saraste, A. et al. Apoptosis in human acute myocardial infarction. Circulation 95, 320\u2013323. https:\/\/doi.org\/10.1161\/01.cir.95.2.320 (1997).","journal-title":"Circulation"},{"key":"17275_CR25","doi-asserted-by":"publisher","first-page":"154999","DOI":"10.1016\/j.phymed.2023.154999","volume":"119","author":"Q Yu","year":"2023","unstructured":"Yu, Q. et al. EGCG attenuated acute myocardial infarction by inhibiting ferroptosis via miR-450b-5p\/ACSL4 axis. Phytomedicine 119, 154999. https:\/\/doi.org\/10.1016\/j.phymed.2023.154999 (2023).","journal-title":"Phytomedicine"},{"key":"17275_CR26","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1186\/s13019-024-03038-6","volume":"19","author":"L Ma","year":"2024","unstructured":"Ma, L. et al. Identification of potential therapeutic targets from bioinformatics analysis of necroptosis and immune infiltration in acute myocardial infarction. J. Cardiothorac. Surg. 19, 524. https:\/\/doi.org\/10.1186\/s13019-024-03038-6 (2024).","journal-title":"J. Cardiothorac. Surg."},{"key":"17275_CR27","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.resuscitation.2008.07.008","volume":"79","author":"J Mersmann","year":"2008","unstructured":"Mersmann, J., Zacharowski, P. A., Schmitz, I. & Zacharowski, K. Caspase inhibitor zVAD.fmk reduces infarct size after myocardial ischaemia and reperfusion in rats but not in mice. Resuscitation 79, 468\u2013474. https:\/\/doi.org\/10.1016\/j.resuscitation.2008.07.008 (2008).","journal-title":"Resuscitation"},{"key":"17275_CR28","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1172\/JCI126428","volume":"129","author":"W Li","year":"2019","unstructured":"Li, W. et al. Ferroptotic cell death and TLR4\/Trif signaling initiate neutrophil recruitment after heart transplantation. J. Clin. Invest. 129, 2293\u20132304. https:\/\/doi.org\/10.1172\/JCI126428 (2019).","journal-title":"J. Clin. Invest."},{"key":"17275_CR29","doi-asserted-by":"publisher","unstructured":"Thygesen, K. et al. Fourth Universal Definition of Myocardial Infarction Circulation 138, e618-e651 (2018). (2018). https:\/\/doi.org\/10.1161\/CIR.0000000000000617","DOI":"10.1161\/CIR.0000000000000617"},{"key":"17275_CR30","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1093\/eurheartj\/ehv071","volume":"36","author":"TF Luscher","year":"2015","unstructured":"Luscher, T. F. Myocardial infarction: mechanisms, diagnosis, and complications. Eur. Heart J. 36, 947\u2013949. https:\/\/doi.org\/10.1093\/eurheartj\/ehv071 (2015).","journal-title":"Eur. Heart J."},{"key":"17275_CR31","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","volume":"44","author":"RA Byrne","year":"2023","unstructured":"Byrne, R. A. et al. 2023 ESC guidelines for the management of acute coronary syndromes. Eur. Heart J. 44, 3720\u20133826. https:\/\/doi.org\/10.1093\/eurheartj\/ehad191 (2023).","journal-title":"Eur. Heart J."},{"key":"17275_CR32","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.ahj.2010.08.039","volume":"160","author":"T Heestermans","year":"2010","unstructured":"Heestermans, T. et al. The golden hour of prehospital reperfusion with triple antiplatelet therapy: a sub-analysis from the ongoing Tirofiban in myocardial evaluation 2 (On-TIME 2) trial early initiation of triple antiplatelet therapy. Am. Heart J. 160, 1079\u20131084. https:\/\/doi.org\/10.1016\/j.ahj.2010.08.039 (2010).","journal-title":"Am. Heart J."},{"key":"17275_CR33","doi-asserted-by":"publisher","first-page":"H1056","DOI":"10.1152\/ajpheart.00459.2021","volume":"321","author":"ML Lindsey","year":"2021","unstructured":"Lindsey, M. L. et al. Guidelines for in vivo mouse models of myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 321, H1056\u2013H1073. https:\/\/doi.org\/10.1152\/ajpheart.00459.2021 (2021).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"17275_CR34","doi-asserted-by":"publisher","DOI":"10.3791\/59591","author":"J Lugrin","year":"2019","unstructured":"Lugrin, J., Parapanov, R., Krueger, T. & Liaudet, L. Murine myocardial infarction model using permanent ligation of left anterior descending coronary artery. J. Vis. Exp. https:\/\/doi.org\/10.3791\/59591 (2019).","journal-title":"J. Vis. Exp."},{"key":"17275_CR35","doi-asserted-by":"publisher","DOI":"10.3791\/52206","author":"I Muthuramu","year":"2014","unstructured":"Muthuramu, I., Lox, M., Jacobs, F. & De Geest, B. Permanent ligation of the left anterior descending coronary artery in mice: a model of post-myocardial infarction remodelling and heart failure. J. Vis. Exp. https:\/\/doi.org\/10.3791\/52206 (2014).","journal-title":"J. Vis. Exp."},{"key":"17275_CR36","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/bph.15595","volume":"179","author":"TP Martin","year":"2022","unstructured":"Martin, T. P. et al. Preclinical models of myocardial infarction: from mechanism to translation. Br. J. Pharmacol. 179, 770\u2013791. https:\/\/doi.org\/10.1111\/bph.15595 (2022).","journal-title":"Br. J. Pharmacol."},{"key":"17275_CR37","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1016\/j.jacc.2011.08.034","volume":"58","author":"EA Liehn","year":"2011","unstructured":"Liehn, E. A., Postea, O., Curaj, A. & Marx, N. Repair after myocardial infarction, between fantasy and reality: the role of chemokines. J. Am. Coll. Cardiol. 58, 2357\u20132362. https:\/\/doi.org\/10.1016\/j.jacc.2011.08.034 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"key":"17275_CR38","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.7150\/ijbs.28103","volume":"14","author":"ZG Ma","year":"2018","unstructured":"Ma, Z. G., Yuan, Y. P., Wu, H. M., Zhang, X. & Tang, Q. Z. Cardiac fibrosis: new insights into the pathogenesis. Int. J. Biol. Sci. 14, 1645\u20131657. https:\/\/doi.org\/10.7150\/ijbs.28103 (2018).","journal-title":"Int. J. Biol. Sci."},{"key":"17275_CR39","doi-asserted-by":"publisher","first-page":"1070973","DOI":"10.3389\/fphar.2023.1070973","volume":"14","author":"X Yin","year":"2023","unstructured":"Yin, X. et al. Post-myocardial infarction fibrosis: pathophysiology, examination, and intervention. Front. Pharmacol. 14, 1070973. https:\/\/doi.org\/10.3389\/fphar.2023.1070973 (2023).","journal-title":"Front. Pharmacol."},{"key":"17275_CR40","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ab.2017.07.009","volume":"552","author":"LD Zorova","year":"2018","unstructured":"Zorova, L. D. et al. Mitochondrial membrane potential. Anal. Biochem. 552, 50\u201359. https:\/\/doi.org\/10.1016\/j.ab.2017.07.009 (2018).","journal-title":"Anal. Biochem."},{"key":"17275_CR41","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/sj.cdd.4400629","volume":"7","author":"Q Chen","year":"2000","unstructured":"Chen, Q., Gong, B. & Almasan, A. Distinct stages of cytochrome c release from mitochondria: evidence for a feedback amplification loop linking caspase activation to mitochondrial dysfunction in genotoxic stress induced apoptosis. Cell. Death Differ. 7, 227\u2013233. https:\/\/doi.org\/10.1038\/sj.cdd.4400629 (2000).","journal-title":"Cell. Death Differ."},{"key":"17275_CR42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1083\/jcb.200208089","volume":"160","author":"JE Ricci","year":"2003","unstructured":"Ricci, J. E., Gottlieb, R. A. & Green, D. R. Caspase-mediated loss of mitochondrial function and generation of reactive oxygen species during apoptosis. J. Cell. Biol. 160, 65\u201375. https:\/\/doi.org\/10.1083\/jcb.200208089 (2003).","journal-title":"J. Cell. Biol."},{"key":"17275_CR43","doi-asserted-by":"publisher","first-page":"103109","DOI":"10.1016\/j.redox.2024.103109","volume":"71","author":"ZY Liu","year":"2024","unstructured":"Liu, Z. Y. et al. Redox homeostasis in cardiac fibrosis: focus on metal ion metabolism. Redox Biol. 71, 103109. https:\/\/doi.org\/10.1016\/j.redox.2024.103109 (2024).","journal-title":"Redox Biol."},{"key":"17275_CR44","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s43440-023-00450-y","volume":"75","author":"H Ushijima","year":"2023","unstructured":"Ushijima, H. & Monzaki, R. An in vitro evaluation of the antioxidant activities of necroptosis and apoptosis inhibitors: the potential of necrostatin-1 and necrostatin-1i to have radical scavenging activities. Pharmacol. Rep. 75, 490\u2013497. https:\/\/doi.org\/10.1007\/s43440-023-00450-y (2023).","journal-title":"Pharmacol. Rep."},{"key":"17275_CR45","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cdtm.2015.02.002","volume":"1","author":"M Tian","year":"2015","unstructured":"Tian, M., Yuan, Y. C., Li, J. Y., Gionfriddo, M. R. & Huang, R. C. Tumor necrosis factor-alpha and its role as a mediator in myocardial infarction: A brief review. Chronic Dis. Transl Med. 1, 18\u201326. https:\/\/doi.org\/10.1016\/j.cdtm.2015.02.002 (2015).","journal-title":"Chronic Dis. Transl Med."},{"key":"17275_CR46","doi-asserted-by":"publisher","unstructured":"Liu, J., Wang, H. & Li, J. Inflammation and inflammatory cells in myocardial infarction and reperfusion injury: A Double-Edged sword. Clin. Med. Insights: Cardiol. 10 https:\/\/doi.org\/10.4137\/cmc.S33164 (2016).","DOI":"10.4137\/cmc.S33164"},{"key":"17275_CR47","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll, S. et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat. Chem. Biol. 13, 91\u201398. https:\/\/doi.org\/10.1038\/nchembio.2239 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"17275_CR48","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.bbrc.2016.08.124","volume":"478","author":"H Yuan","year":"2016","unstructured":"Yuan, H., Li, X., Zhang, X., Kang, R. & Tang, D. Identification of ACSL4 as a biomarker and contributor of ferroptosis. Biochem. Biophys. Res. Commun. 478, 1338\u20131343. https:\/\/doi.org\/10.1016\/j.bbrc.2016.08.124 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"17275_CR49","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s41419-019-2061-8","volume":"10","author":"TJ Park","year":"2019","unstructured":"Park, T. J. et al. Quantitative proteomic analyses reveal that GPX4 downregulation during myocardial infarction contributes to ferroptosis in cardiomyocytes. Cell. Death Dis. 10, 835. https:\/\/doi.org\/10.1038\/s41419-019-2061-8 (2019).","journal-title":"Cell. Death Dis."},{"key":"17275_CR50","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1089\/ars.2009.3036","volume":"13","author":"M Shakibaei","year":"2010","unstructured":"Shakibaei, M., Sung, B., Sethi, G. & Aggarwal, B. B. TNF-alpha-induced mitochondrial alterations in human T cells requires FADD and caspase-8 activation but not RIP and caspase-3 activation. Antioxid. Redox Signal. 13, 821\u2013831. https:\/\/doi.org\/10.1089\/ars.2009.3036 (2010).","journal-title":"Antioxid. Redox Signal."},{"key":"17275_CR51","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.3389\/fphar.2018.01378","volume":"9","author":"S Liang","year":"2018","unstructured":"Liang, S. et al. Necrostatin-1 attenuates Trauma-Induced mouse osteoarthritis and IL-1beta induced apoptosis via HMGB1\/TLR4\/SDF-1 in primary mouse chondrocytes. Front. Pharmacol. 9, 1378. https:\/\/doi.org\/10.3389\/fphar.2018.01378 (2018).","journal-title":"Front. Pharmacol."},{"key":"17275_CR52","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s11064-012-0791-4","volume":"37","author":"YQ Wang","year":"2012","unstructured":"Wang, Y. Q. et al. Necrostatin-1 suppresses autophagy and apoptosis in mice traumatic brain injury model. Neurochem Res. 37, 1849\u20131858. https:\/\/doi.org\/10.1007\/s11064-012-0791-4 (2012).","journal-title":"Neurochem Res."},{"key":"17275_CR53","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.neuroscience.2014.12.061","volume":"289","author":"Y Wang","year":"2015","unstructured":"Wang, Y. et al. Necrostatin-1 mitigates mitochondrial dysfunction post-spinal cord injury. Neuroscience 289, 224\u2013232. https:\/\/doi.org\/10.1016\/j.neuroscience.2014.12.061 (2015).","journal-title":"Neuroscience"},{"key":"17275_CR54","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41598-017-18935-1","volume":"8","author":"C Wu","year":"2018","unstructured":"Wu, C. et al. Induction of ferroptosis and mitochondrial dysfunction by oxidative stress in PC12 cells. Sci. Rep. 8, 574. https:\/\/doi.org\/10.1038\/s41598-017-18935-1 (2018).","journal-title":"Sci. Rep."},{"key":"17275_CR55","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1161\/CIRCRESAHA.110.223925","volume":"107","author":"E Gao","year":"2010","unstructured":"Gao, E. et al. A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse. Circ. Res. 107, 1445\u20131453. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.223925 (2010).","journal-title":"Circ. Res."},{"key":"17275_CR56","doi-asserted-by":"publisher","DOI":"10.3791\/1438","author":"MV Kolk","year":"2009","unstructured":"Kolk, M. V. et al. LAD-ligation: a murine model of myocardial infarction. J. Vis. Exp. https:\/\/doi.org\/10.3791\/1438 (2009).","journal-title":"J. Vis. Exp."},{"key":"17275_CR57","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jchf.2017.09.015","volume":"6","author":"MC Bahit","year":"2018","unstructured":"Bahit, M. C., Kochar, A. & Granger, C. B. Post-Myocardial infarction heart failure. JACC Heart Fail. 6, 179\u2013186. https:\/\/doi.org\/10.1016\/j.jchf.2017.09.015 (2018).","journal-title":"JACC Heart Fail."},{"key":"17275_CR58","doi-asserted-by":"publisher","unstructured":"Khan, M. S. et al. Dose of angiotensin-Converting enzyme inhibitors and angiotensin receptor blockers and outcomes in heart failure: A Meta-Analysis. Circ. Heart Fail. 10 https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.117.003956 (2017).","DOI":"10.1161\/CIRCHEARTFAILURE.117.003956"},{"key":"17275_CR59","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/0140-6736(92)92889-n","volume":"340","author":"S Yusuf","year":"1992","unstructured":"Yusuf, S. et al. Effect of Enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 340, 1173\u20131178. https:\/\/doi.org\/10.1016\/0140-6736(92)92889-n (1992).","journal-title":"Lancet"},{"key":"17275_CR60","doi-asserted-by":"publisher","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M. & Altman, D. G. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 8, e1000412. https:\/\/doi.org\/10.1371\/journal.pbio.1000412 (2010).","journal-title":"PLoS Biol."},{"key":"17275_CR61","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1042\/CS20220074","volume":"136","author":"C Maneechote","year":"2022","unstructured":"Maneechote, C. et al. Promoting mitochondrial fusion in doxorubicin-induced cardiotoxicity: a novel therapeutic target for cardioprotection. Clin. Sci. (Lond). 136, 841\u2013860. https:\/\/doi.org\/10.1042\/CS20220074 (2022).","journal-title":"Clin. Sci. (Lond)"},{"key":"17275_CR62","doi-asserted-by":"publisher","first-page":"177685","DOI":"10.1016\/j.ejphar.2025.177685","volume":"999","author":"C Maneechote","year":"2025","unstructured":"Maneechote, C. et al. Targeting mitochondrial dynamics emerges as an effective strategy of cardioprotection against trastuzumab-induced mitochondrial functional aberrations and cardiotoxicity in rats. Eur. J. Pharmacol. 999, 177685. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177685 (2025).","journal-title":"Eur. J. Pharmacol."},{"key":"17275_CR63","doi-asserted-by":"publisher","first-page":"105882","DOI":"10.1016\/j.phrs.2021.105882","volume":"173","author":"T Khuanjing","year":"2021","unstructured":"Khuanjing, T. et al. Acetylcholinesterase inhibitor ameliorates doxorubicin-induced cardiotoxicity through reducing RIP1-mediated necroptosis. Pharmacol. Res. 173, 105882. https:\/\/doi.org\/10.1016\/j.phrs.2021.105882 (2021).","journal-title":"Pharmacol. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17275-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17275-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17275-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T05:02:13Z","timestamp":1756443733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17275-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,24]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["17275"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-17275-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,24]]},"assertion":[{"value":"11 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experimental procedures were rigorously conducted in accordance with the Guide for the Care and Use of Laboratory Animals and were approved by the Chiang Mai University Animal Care and Use Committee, Chiang Mai University (approval number 2564\/RT-0014), and the Laboratory Animal Center (Office of Research Administration, Chiang Mai University).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"31140"}}